Hairy cell leukemia differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 3: Line 3:
{{CMG}} {{AE}}{{HL}}
{{CMG}} {{AE}}{{HL}}
==Overview==
==Overview==
* Chronic lymphocytic leukemia must be differentiated from other diseases that cause [[weight loss]], [[night sweats]], [[hepatosplenomegaly]], and palpable [[lymph node]]s, such as [[hairy cell leukaemia]], prolymphocytic leukaemia, [[follicular lymphoma]], and [[mantle cell lymphoma]].<ref name="H">Hoffbrand V, Moss P. Essential Haematology. John Wiley & Sons; 2011</ref>
* Hairy cell leukemia must be differentiated from other diseases that cause [[weight loss]], [[fatigue]], [[splenomegaly]], and fever, such as [[chronic lymphocytic leukaemia]], prolymphocytic leukaemia, [[follicular lymphoma]], and [[mantle cell lymphoma]].<ref name="H">Hoffbrand V, Moss P. Essential Haematology. John Wiley & Sons; 2011</ref>


==Differenting Chronic lymphocytic leukemia from other Diseases==
==Differenting Hairy cell leukemia from other Diseases==
* Chronic lymphocytic leukemia must be differentiated from other diseases that cause [[weight loss]], [[night sweats]], [[hepatosplenomegaly]], and palpable [[lymph node]]s, such as [[hairy cell leukaemia]], prolymphocytic leukaemia, [[follicular lymphoma]], and [[mantle cell lymphoma]].
* Hairy cell leukemia must be differentiated from other diseases that cause [[weight loss]], [[fatigue]], [[splenomegaly]], and fever, such as [[chronic lymphocytic leukaemia]], prolymphocytic leukaemia, [[follicular lymphoma]], and [[mantle cell lymphoma]].<ref name="H">Hoffbrand V, Moss P. Essential Haematology. John Wiley & Sons; 2011</ref>
* Based on the expression of cell surface markers, the table below differentiates chronic lymphocytic leukemia from other diseases that cause similar clinical presentations:<ref name="H">Hoffbrand V, Moss P. Essential Haematology. John Wiley & Sons; 2011</ref>
<br>
<br>
{| style="border: 0px; font-size: 90%; margin: 3px; width: 1000px"
{| style="border: 0px; font-size: 90%; margin: 3px; width: 1000px"
Line 23: Line 22:


| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
'''Chronic lymphocytic leukaemia'''
'''Hairy cell leukaemia'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center |
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
'''Weakly positive'''
'''Strongly positive'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center |
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
'''Positive'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center |
'''Negative'''
'''Negative'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
Line 36: Line 33:
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
'''Positive/Negative'''
'''Positive/Negative'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
'''Positive'''


|-
|-


| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
'''Prolymphocytic leukaemia'''
'''Chronic lymphocytic leukaemia'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
| style="padding: 5px 5px; background: #F5F5F5;" align=center |
'''Strongly positive'''
'''Weakly positive'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
| style="padding: 5px 5px; background: #F5F5F5;" align=center |
'''Positive'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center |
'''Negative'''
'''Negative'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
Line 50: Line 51:
'''Negative'''
'''Negative'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
'''Positive'''
'''Positive/Negative'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
'''Negative'''


|-
|-


| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
'''Hairy cell leukaemia'''
'''Prolymphocytic leukaemia'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
'''Strongly positive'''
'''Strongly positive'''
Line 67: Line 66:
'''Negative'''
'''Negative'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
'''Positive/Negative'''
'''Positive'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
'''Positive'''
'''Negative'''


|-
|-
Line 106: Line 105:
|}
|}
<br>
<br>
* Chronic lymphocytic leukemia must also be differentiated from other causes of fever, hepatosplenomegaly, and lymph node swelling such as:<ref name="wiki">Chronic Lymphocytic Leukimea. Wikipedia (2015) https://en.wikipedia.org/wiki/B-cell_chronic_lymphocytic_leukemia Accessed on October ,12 2015</ref>
* Hairy cell leukemia must also be differentiated from other causes of fever, splenomegaly, and fatigue such as:<ref name="wiki">Hairy Cell Leukimea. Wikipedia (2015) https://en.wikipedia.org/wiki/Hairy_cell_leukemia#Pathophysiology Accessed on October ,21 2015</ref>
:* [[Splenic marginal zone lymphoma]]
:* Aplastic anemia
:* Nodal marginal zone [[lymphoma]]
:* Myelodysplastic syndrome
:* [[Lymphoplasmacytic lymphoma]]
:* B-cell prolymphocytic leukemia
:* [[Sézary syndrome]]
:* Idiopathic myelofibrosis
:* Smoldering [[adult T cell leukemia]]
 
==References==
==References==
{{reflist|2}}
{{reflist|2}}

Revision as of 11:22, 21 October 2015

Hairy cell leukemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hairy cell leukemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hairy cell leukemia differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hairy cell leukemia differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hairy cell leukemia differential diagnosis

CDC on Hairy cell leukemia differential diagnosis

Hairy cell leukemia differential diagnosis in the news

Blogs on Hairy cell leukemia differential diagnosis

Directions to Hospitals Treating Hairy cell leukemia

Risk calculators and risk factors for Hairy cell leukemia differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]

Overview

Differenting Hairy cell leukemia from other Diseases


Differential Diagnosis Surface Immunoglobulin CD5 CD22/FMC7 CD23 CD79b CD103

Hairy cell leukaemia

Strongly positive

Negative

Positive

Negative

Positive/Negative

Positive

Chronic lymphocytic leukaemia

Weakly positive

Positive

Negative

Positive

Negative

Positive/Negative

Prolymphocytic leukaemia

Strongly positive

Negative

Positive

Negative

Positive

Negative

Mantle cell lymphoma

Positive

Positive

Strongly positive

Negative

Strongly positive

Negative

Follicular lymphoma

Strongly positive

Negative

Positive

Negative

Strongly positive

Negative


  • Hairy cell leukemia must also be differentiated from other causes of fever, splenomegaly, and fatigue such as:[2]
  • Aplastic anemia
  • Myelodysplastic syndrome
  • B-cell prolymphocytic leukemia
  • Idiopathic myelofibrosis

References

  1. 1.0 1.1 Hoffbrand V, Moss P. Essential Haematology. John Wiley & Sons; 2011
  2. Hairy Cell Leukimea. Wikipedia (2015) https://en.wikipedia.org/wiki/Hairy_cell_leukemia#Pathophysiology Accessed on October ,21 2015


Template:WikiDoc Sources